General Information of the Compound
| Compound ID |
CP0855714
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R,4aR,10aR)-2-(4-Chloro-pyrazol-1-ylmethyl)-4-propyl-3,4,4a,5,10,10a-hexahydro-2H-naphtho[2,3-b][1,4]oxazin-9-ol hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H25Cl2N3O2
|
||||||||||||||||||
| Molecular Weight |
398.334
|
||||||||||||||||||
| Canonical SMILES |
CCCN1C[C@H](Cn2cc(Cl)cn2)O[C@@H]2Cc3c(O)cccc3C[C@H]21.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H24ClN3O2.ClH/c1-2-6-22-11-15(12-23-10-14(20)9-21-23)25-19-8-16-13(7-17(19)22)4-3-5-18(16)24;/h3-5,9-10,15,17,19,24H,2,6-8,11-12H2,1H3;1H/t15-,17-,19-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
IOAZCIZEMHPCAC-YFLXZMGJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor